Learning Objectives:

1.  Understand the rationale for using immune checkpoint blockade as a tool for preventing progression to oral cancer.

2.  Appreciate the evolving impact of plasma HPV ctDNA on diagnosis, surveillance, and as a potential biomarker across the HPV cancer spectrum

3.  Understand how immune effector cell therapies are being applied to solid tumors (not just hematologic malignancies)

Session date: 
01/24/2022 - 12:00pm to 1:00pm CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Glenn Hanna, MD